107 related articles for article (PubMed ID: 15699906)
21. [Comparison of clinical and surgico-pathological TNM stage of 2007 lung cancer patients].
Huang GJ; Zhang DC; Mao YS; Li J; Wang YG; Wang DL; Xue Q; Gao SG; Zhang LZ; Lei WD; Gao YS; Zhao J; Huang JF; Yang K; Su K; Zhu SY; Wei S; Feng FY
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):551-3. PubMed ID: 16438855
[TBL] [Abstract][Full Text] [Related]
22. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients.
Ichinose Y; Hara N; Ohta M; Yano T; Maeda K; Asoh H; Katsuda Y
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):90-4. PubMed ID: 8391613
[TBL] [Abstract][Full Text] [Related]
23. Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage II.
Toffalorio F; Radice D; Spaggiari L; Sinno V; Barberis M; Spitaleri G; Giovannini M; Delmonte A; Catania C; Noberasco C; Brambilla D; de Braud F; Veronesi G; Solli P; De Pas T
J Thorac Oncol; 2012 Jul; 7(7):1124-30. PubMed ID: 22610258
[TBL] [Abstract][Full Text] [Related]
24. Surgery for young patients with lung cancer.
Tian DL; Liu HX; Zhang L; Yin HN; Hu YX; Zhao HR; Chen DY; Han LB; Li Y; Li HW
Lung Cancer; 2003 Nov; 42(2):215-20. PubMed ID: 14568689
[TBL] [Abstract][Full Text] [Related]
25. Survival after conservative resection for T1 N0 M0 non-small cell lung cancer.
Read RC; Yoder G; Schaeffer RC
Ann Thorac Surg; 1990 Mar; 49(3):391-8; discussion 399-400. PubMed ID: 2155592
[TBL] [Abstract][Full Text] [Related]
26. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993.
Inoue K; Sato M; Fujimura S; Sakurada A; Takahashi S; Usuda K; Kondo T; Tanita T; Handa M; Saito Y; Sagawa M
J Thorac Cardiovasc Surg; 1998 Sep; 116(3):407-11. PubMed ID: 9731782
[TBL] [Abstract][Full Text] [Related]
27. Reasons for the delays in the definitive diagnosis of lung cancer for more than one year from the recognition of abnormal chest shadows.
Yoshimoto A; Tsuji H; Takazakura E; Watanabe T; Haratake J; Kasahara K; Fujimura M; Nakao S
Intern Med; 2002 Feb; 41(2):95-102. PubMed ID: 11868615
[TBL] [Abstract][Full Text] [Related]
28. Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging.
Stiles BM; Servais EL; Lee PC; Port JL; Paul S; Altorki NK
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):13-9. PubMed ID: 19154893
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
[TBL] [Abstract][Full Text] [Related]
30. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
31. [Association of HAb18G with clinicopathologic features and prognosis in non-small cell carcinoma of lung].
Xu XY; Zhi C; Li YM; Qi WJ; Mei JJ; Yan ZM; Shen H
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):151-5. PubMed ID: 22800476
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1-3 N0 M0 non-small cell lung cancer: NCIC CTG BR.25.
Cheung P; Faria S; Ahmed S; Chabot P; Greenland J; Kurien E; Mohamed I; Wright JR; Hollenhorst H; de Metz C; Campbell H; Vu TT; Karvat A; Wai ES; Ung YC; Goss G; Shepherd FA; O'Brien P; Ding K; O'Callaghan C
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25074417
[TBL] [Abstract][Full Text] [Related]
33. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
34. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification.
Christian C; Erica S; Morandi U
Lung Cancer; 2006 Nov; 54(2):185-91. PubMed ID: 16996167
[TBL] [Abstract][Full Text] [Related]
35. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location.
Kotoulas CS; Foroulis CN; Kostikas K; Konstantinou M; Kalkandi P; Dimadi M; Bouros D; Lioulias A
Lung Cancer; 2004 May; 44(2):183-91. PubMed ID: 15084383
[TBL] [Abstract][Full Text] [Related]
36. Comparative efficacy and toxicity of induction chemotherapy with concurrent stereotactic body radiotherapy and stereotactic body radiotherapy with subsequent chemotherapy in patients with clinical stage T1-3N0M0 non-small cell lung carcinoma.
Sun Y; Duan Q; Chen X; Chen W; Jin X; Wu R
Clin Transl Oncol; 2017 Dec; 19(12):1498-1506. PubMed ID: 28589432
[TBL] [Abstract][Full Text] [Related]
37. Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer.
Harris JP; Nwachukwu C; Qian Y; Pollom E; Loo BW; Das M; Diehn M
Lung Cancer; 2018 Oct; 124():76-85. PubMed ID: 30268484
[TBL] [Abstract][Full Text] [Related]
38. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
39. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
[TBL] [Abstract][Full Text] [Related]
40. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
